Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir: A Randomized, Placebo-Controlled Trial | Zendy

Peter L. Havens | Zendy; Charles B. Stephensen | Zendy; Rohan Hazra | Zendy; Patricia M. Flynn | Zendy; Craig M. Wilson | Zendy; Brandy Rutledge | Zendy; James Bethel | Zendy; ChiFeng Pan | Zendy; L. R. Woodhouse | Zendy; Marta D. Van Loan | Zendy; Nancy Liu | Zendy; Jorge LujánZilbermann | Zendy; Alyne Baker | Zendy; Bill G. Kapogiannis | Zendy; Kathleen Mulligan | Zendy

Open Access

Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir: A Randomized, Placebo-Controlled Trial

Author(s) -

Peter L. Havens,

Charles B. Stephensen,

Rohan Hazra,

Patricia M. Flynn,

Craig M. Wilson,

Brandy Rutledge,

James Bethel,

ChiFeng Pan,

L. R. Woodhouse,

Marta D. Van Loan,

Nancy Liu,

Jorge LujánZilbermann,

Alyne Baker,

Bill G. Kapogiannis,

Kathleen Mulligan

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir968

Subject(s) - medicine , placebo , parathyroid hormone , vitamin d and neurology , endocrinology , vitamin d deficiency , randomized controlled trial , gastroenterology , vitamin , calcium , pathology , alternative medicine

The study goal was to determine the effect of vitamin D (VITD) supplementation on tubular reabsorption of phosphate (TRP), parathyroid hormone (PTH), bone alkaline phosphatase (BAP), and C-telopeptide (CTX) in youth infected with human immunodeficiency virus (HIV) receiving and not receiving combination antiretroviral therapy (cART) containing tenofovir disoproxil fumarate (TDF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research